FFRct vs Eko Low Ejection Fraction Tool (ELEFT)
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (FFRct) is a diagnostic tool for coronary artery disease, leveraging CCTA scans to create 3D models and assess blood flow. Tool B (ELEFT) is a screening tool for low ejection fraction, an indicator of heart failure, utilizing digital stethoscope data during routine exams. While both are cardiology AI, they address different cardiac conditions and stages of patient care, making them complementary rather than directly competitive.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is designed to aid in diagnosing coronary artery disease (CAD) by assessing blood flow in coronary arteries. The Eko Low Ejection Fraction Tool (ELEFT) focuses on the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
HeartFlow FFRct Analysis utilizes data from CCTA (Coronary CT Angiography) scans to create personalized 3D models of coronary arteries. Eko's ELEFT integrates with Eko digital stethoscopes to analyze ECG and heart sound recordings.
FFRct generates personalized 3D digital models of coronary arteries and analyzes blood flow to provide FFRct values, which help identify areas of narrowing and aid in diagnosing CAD and guiding treatment strategies. ELEFT provides AI-powered detection of low ejection fraction, with results available in approximately 15 seconds, assisting in the early identification of heart failure risk.
HeartFlow FFRct Analysis is primarily utilized by Cardiology and Radiology specialists. The Eko Low Ejection Fraction Tool (ELEFT) is designed for use across Cardiology, Family Medicine, and Internal Medicine.
More Comparisons
Backers
Who funded each tool's parent company.